SCHEMBL4820296

SCHEMBL4820296

N#CC(C#N)=Cc1cccc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.56
APP P05067 3/20 0.53
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 4/20 0.51
MAPT P10636 4/20 0.51
LMNA P02545 4/20 0.51
PLEC Q15149 1/20 0.51
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
SNCA P37840 1/20 0.44
POLB P06746 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
GRIN2D O15399 2/20 0.42
GRIN3B O60391 2/20 0.42
GRIN1 Q05586 2/20 0.42
GRIN2A Q12879 2/20 0.42
GRIN2B Q13224 2/20 0.42
GRIN2C Q14957 2/20 0.42
GRIN3A Q8TCU5 2/20 0.42
PIP4K2A P48426 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29981581 1.00 TRPA1 (0.56) TRPA1APPKDM4EALDH1A1MAPT
Dimethylamine SCHEMBL6748737 0.93 KMT2A (0.53) TRPA1APPKDM4EALDH1A1MAPT
SCHEMBL9848553 0.84 TRPA1 (0.51) TRPA1APPKDM4EALDH1A1MAPT
SCHEMBL13938652 0.81 KDM4E (0.48) KDM4EALDH1A1MAPTLMNAPLEC
SCHEMBL9735148 0.79 ALDH1A1 (0.50) APPKDM4EALDH1A1MAPTLMNA
SCHEMBL29164994 0.79 PIP4K2A (0.53) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL9735153 0.79 ALDH1A1 (0.50) APPKDM4EALDH1A1MAPTLMNA
SCHEMBL4661306 0.78 CRHBP (0.60) KDM4EALDH1A1MAPTLMNAKMT2A
SCHEMBL4661300 0.78 CRHBP (0.60) KDM4EALDH1A1MAPTLMNAKMT2A
SCHEMBL11855887 0.78 CRHBP (0.41) KDM4EALDH1A1MAPTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118287150-A Method for efficiently catalyzing Knoevenagel condensation reaction by porphyrin and quaternary ammonium salt synergistic catalytic system 沈阳药科大学 2024-07-05 CN disclosed
CN-113135856-B 3-trifluoromethyl-5-cyanopyrazole compounds and preparation method thereof 天津大学 2022-10-11 CN disclosed
CN-113135856-A 3-trifluoromethyl-5-cyanopyrazole compounds and preparation method thereof 天津大学 2021-07-20 CN disclosed
US-20180141911-A1 Quinoline Derivatives for Diagnosis and Treatment of Alzheimer's Disease NORTHEASTERN UNIVERSITY 2018-05-24 US disclosed
WO-2016183578-A1 QUINOLINE DERIVATIVES FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE NORTHEASTERN UNIVERSITY (US) 2016-11-17 WO disclosed
CN-103804268-B A kind of method efficiently synthesizing the functionalization enamine with high regioselectivity 陕西师范大学 2016-06-29 CN disclosed
CN-103804268-A Method for efficiently synthesizing functional enamine with high regioselectivity UNIV SHAANXI NORMAL 2014-05-21 CN disclosed
US-7425580-B2 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands WYETH (US) 2008-09-16 US disclosed
EP-1747192-A1 (DIARYL-METHYL)-MALONONITRILES AND THEIR USE AS ESTROGEN RECEPTOR LIGANDS Wyeth (US) 2007-01-31 EP disclosed
US-20060014831-A1 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands WYETH (US) 2006-01-19 US disclosed
WO-2005121076-A1 (DIARYL-METHYL)-MALONONITRILES AND THEIR USE AS ESTROGEN RECEPTOR LIGANDS WYETH (US) 2005-12-22 WO disclosed
US-4184871-A A,B-UNSATURATED NITRILE SENSITIZER MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) 1980-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014831-A1 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands ESR1, ESR2, GPER1 TRPA1 1039/4885APP 4289/4885KDM4E 286/4885
US-20180141911-A1 Quinoline Derivatives for Diagnosis and Treatment of Alzheimer's Disease MAPT, PSEN1, PSEN2 TRPA1 3875/4885APP 4/4885KDM4E 3865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.